A new global study shows that an immunotherapy drug can delay the onset of Type 1 diabetes for two years in high-risk kids and adults. The study ran in 28 research sites. Trial results are great news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback